Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Monica Sokil"'
Publikováno v:
JAMA Dermatol
Importance Topical calcineurin inhibitors (TCIs), primarily used to treat atopic dermatitis (AD), carry a black box label warning users about the potential for increased skin cancer risk. The risk associated with keratinocyte carcinoma (KC), the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::657a6b59e121e59b69a55eacf6f0a048
https://europepmc.org/articles/PMC7557510/
https://europepmc.org/articles/PMC7557510/
Autor:
Zheng Zhu, Gary D. Friedman, Monica Sokil, Katherine A. Levandoski, Romain Neugebauer, Mary-Margaret Chren, Maryam M. Asgari
Publikováno v:
Journal of the American Academy of Dermatology. 78:710-716
Background The most widely used topical agents for the field-based treatment of multiple actinic keratoses (AKs) are 5-fluorouracil and imiquimod, but their comparative effectiveness has not been assessed in a real-world setting. Objective We compare
Publikováno v:
British Journal of Dermatology. 177:428-435
Background Acral lentiginous melanoma (ALM) is a rare melanoma subtype that disproportionately afflicts people of colour. ALMs have a worse prognosis than other melanoma subtypes; this has been attributed to aggressive biological behaviour, more adva
Autor:
Gary D. Friedman, Katherine A. Su, Romain Neugebauer, Monica Sokil, Zheng Zhu, Maryam M. Asgari, Mary-Margaret Chren
Publikováno v:
Journal of the American Academy of Dermatology. 80(4)
Background The effectiveness of 5-fluorouracil compared with that of imiquimod for preventing keratinocyte carcinoma is unknown. Objective To compare the effectiveness of 5-fluorouracil and that of imiquimod in preventing keratinocyte carcinoma in a
Autor:
Jayasri G. Iyer, Stephanie Pietromonaco, William T. Simonson, Kelly G. Paulson, Renee Thibodeau, Monica Sokil, Astrid Blom, Maryam M. Asgari, Miranda Schmidt, E. Margaret Warton, Paul Nghiem
Publikováno v:
American Journal of Clinical Pathology. 142:452-458
Merkel cell carcinoma (MCC) is a skin cancer with a reported incidence rate that has almost quadrupled in the past two decades in the United States1 and has an often-aggressive disease course (disease-associated mortality of 46%).2 Although recently
Autor:
Monica Sokil, Kelly G. Paulson, Astrid Blom, Shailender Bhatia, Lola Yelistratova, Jayasri G. Iyer, Paul Nghiem, E. Margaret Warton, Maryam M. Asgari, Kotaro Nagase, Louise Schuman
Publikováno v:
Journal of Investigative Dermatology. 133(3):642-646
Merkel cell carcinoma (MCC) is an aggressive cutaneous malignancy linked to a contributory virus (Merkel cell polyomavirus). Multiple epidemiologic studies have established an increased incidence of MCC among persons with systemic immune suppression.
Autor:
Kelly G, Paulson, Jayasri G, Iyer, William T, Simonson, Astrid, Blom, Renee M, Thibodeau, Miranda, Schmidt, Stephanie, Pietromonaco, Monica, Sokil, E Margaret, Warton, Maryam M, Asgari, Paul, Nghiem
Publikováno v:
American journal of clinical pathology. 142(4)
Intratumoral CD8+ lymphocytes (IT-CD8s) have shown promise as a prognostic indicator for Merkel cell carcinoma (MCC). We tested whether IT-CD8s predict survival among a population-based MCC cohort.One hundred thirty-seven MCC cases that had not previ
Autor:
Monica Sokil, Jayasri G. Iyer, E. Margaret Warton, Paul Nghiem, Kelly G. Paulson, Maryam M. Asgari
Publikováno v:
JAMA Dermatology. 150:716
Importance Merkel cell carcinoma (MCC) is a rare, aggressive, neuroendocrine-derived skin cancer with high rates of recurrence and associated mortality. Few published studies have used comprehensive patient data and long-term follow-up to examine fac